TreeFrog Therapeutics
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $56M
Investors
- 10
About TreeFrog Therapeutics
TreeFrog Therapeutics, established in 2018 in France, specializes in advanced cell therapies. The company was co-founded by Erwan Bezard and Kévin Alessandri, and operates its headquarters in Bordeaux.TreeFrog Therapeutics specializes in the development of advanced cell therapies, focusing primarily on regenerative medicine. The company's key product targets Parkinson's Disease, utilizing a proprietary 3D microtissue format that enhances cell survival and ensures effective dose control. This is made possible through their innovative C-Stem™ technology platform, which incorporates GMP-compliant encapsulation, allowing for large-scale production of over 1,000 capsules per second.2.645 mn since its founding to support R&D initiatives in stem cell technology, with a structured revenue model based on partnerships and out-licensing agreements for its C-Stem™ technology. The company is also focused on the development and launch of new therapies targeting liver diseases and expanding its reach into global markets, particularly in North America and Europe, by leveraging its innovative C-Stem™ platform.
Who invested in TreeFrog Therapeutics
10 investors across 3 rounds
See all investors in TreeFrog Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TreeFrog Therapeutics
Who invested in TreeFrog Therapeutics?
TreeFrog Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TreeFrog Therapeutics raised?
TreeFrog Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did TreeFrog Therapeutics last raise money?
TreeFrog Therapeutics's most recent round on record is a Series B, in Sep 2021.
What does TreeFrog Therapeutics do?
TreeFrog Therapeutics, established in 2018 in France, specializes in advanced cell therapies.
Where is TreeFrog Therapeutics headquartered?
TreeFrog Therapeutics is headquartered in France.
Which VCs invest in companies like TreeFrog Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at TreeFrog Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TreeFrog Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.